
The difference between MGUS and myeloma
Ellen Watters, one of our Myeloma Information Specialists, discusses some of the differences between monoclonal gammopathy of undetermined significance (MGUS) and myeloma, such as in monitoring, symptoms and treatment.
Correction [0:56]: If MGUS remains stable and the patient does not experience any new or increasing symptoms, then monitoring can *decrease*.
This content is part of the MGUS quick guide video series collection
Discover the full libraryBrowse library content

Stay in touch
We’d love to stay in touch. Join our mailing list to receive updates from Myeloma UK including our monthly newsletter and updates about our services, research, campaigns and other ways you can get involved.






